A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer

NCT03749083 · clinicaltrials.gov ↗

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding

Conditions

Gastrointestinal Malignancies

Interventions

OTHER: The Functional Assessment of Cancer Therapy- Colorectal

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]